SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000946644-14-000008
Filing Date
2014-05-09
Accepted
2014-05-09 16:04:17
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q heb-2014033110q.htm 10-Q 750738
2 EXHIBIT copyofheb-20140331xex311.htm EX-31.1 13385
3 EXHIBIT copyofheb-20140331xex312.htm EX-31.2 13452
4 EXHIBIT copyofheb-20140331xex321.htm EX-32.1 6620
5 EXHIBIT copyofheb-20140331xex322.htm EX-32.2 6722
  Complete submission text file 0000946644-14-000008.txt   5399384

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20140331.xml EX-101.INS 842342
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT heb-20140331.xsd EX-101.SCH 36615
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT heb-20140331_cal.xml EX-101.CAL 51019
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT heb-20140331_def.xml EX-101.DEF 145797
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT heb-20140331_lab.xml EX-101.LAB 454871
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT heb-20140331_pre.xml EX-101.PRE 255430
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 14829039
SIC: 2836 Biological Products, (No Diagnostic Substances)